About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CLBS - Caladrius Bioscience...| Previous Close | $1.49 | Open | |
| Volume | Market Cap | 30.73M | |
| Yield | Last Dividend |
| Embryonic Stem Cell Market to see Huge G... | 11/23/20 |
| Latest released the research study on Global Embryonic Stem Cell Market, offers a detailed overview of the factors influencing the global business sco... | |
| Caladrius Biosciences to Present at Amer... | 11/10/20 |
| BASKING RIDGE, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-s... | |
| Caladrius Biosciences Announces Particip... | 11/04/20 |
| BASKING RIDGE, N.J. , Nov. 04, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-... | |
| Caladrius Biosciences Appoints Industry ... | 11/02/20 |
| BASKING RIDGE, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-s... | |
| Caladrius Bio launches CLBS119 study to ... | 10/08/20 |
| Caladrius Biosciences (NASDAQ:CLBS) has opened its proof-of-concept study of CLBS119 (peripheral blood-derived autologous CD34+ cells) as a treatment ... | |
| Caladrius Biosciences to Present at the ... | 10/06/20 |
| BASKING RIDGE, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-s... | |
| Caladrius Biosciences to Present at H.C.... | 09/08/20 |
| BASKING RIDGE, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-... | |
| Caladrius Biosciences to Host Second Qua... | 08/06/20 |
| BASKING RIDGE, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-s... | |
| Caladrius Biosciences Announces the Resi... | 08/05/20 |
| BASKING RIDGE, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-s... | |
| Caladrius Biosciences Appoints Dr. Micha... | 07/28/20 |
| BASKING RIDGE, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a clinical-s... | |
| The Daily Biotech Pulse: Mylan Ramps Up ... | 03/20/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) ... | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| The Daily Biotech Pulse: Therapix Calls ... | 11/08/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs N... | |
| Caladrius Biosciences to Participate at ... | 10/31/19 |
| BASKING RIDGE, N.J., Oct. 31, 2019 -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a late-stage therapeutics dev... | |
| Is Caladrius Biosciences (NASDAQ:CLBS) I... | 10/23/19 |
| There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com??? | |
| The Daily Biotech Pulse: UCB To Buy Ra P... | 10/10/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) A... | |
| Caladrius Biosciences to Participate at ... | 10/01/19 |
| BASKING RIDGE, N.J., Oct. 01, 2019 -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a late-stage therapeutics dev... | |
| The Daily Biotech Pulse: Chiasma To Join... | 06/28/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on June 27) ... | |
| The Daily Biotech Pulse: Vertex Bets Big... | 06/07/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 6) B... | |
| The Daily Biotech Pulse: Takeda Pulls Pl... | 06/06/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 5) A... | |
| Caladrius Biosciences, Inc.'s (CLBS) CEO... | 05/09/19 |
| Caladrius Biosciences, Inc. (NASDAQ:CLBS) Q1 2019 Results Earnings Conference Call May 09, 2019, 04:30 PM ET Company Participants John Menditto - VP I... | |
| Caladrius Biosciences to Participate at ... | 05/07/19 |
| BASKING RIDGE, N.J., May 07, 2019 -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (???Caladrius??? or the ???Company???), a late-stage therapeutics deve... | |
| The Daily Biotech Pulse: FDA Nod For San... | 05/02/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Al... | |
| How Does Caladrius Biosciences, Inc. (NA... | 04/25/19 |
| If you're interested in Caladrius Biosciences, Inc. (NASDAQ:CLBS), then you might want to consider its beta (a measure of share price volatility) in o... | |
| BTE, BRSS, WVE and FLXN among notable mi... | 04/10/19 |
| No summary available. | |
| Caladrius Biosciences reports Q4 results | 03/14/19 |
| No summary available. | |
| SWIR, NGD, CYBR and PDS among notable mi... | 02/14/19 |
| No summary available. | |
| Omeros and Vanda Pharmaceuticals among h... | 02/14/19 |
| No summary available. | |
| Caladrius down 23% on disappointing CLBS... | 02/14/19 |
| No summary available. | |
| Caladrius Biosciences (CLBS) Investor Pr... | 02/12/19 |
| The following slide deck was published by Caladrius Biosciences, Inc. in conjunction with this event. | |
| Date | 2020-11-05 (AMC) | Est. (EPS/Rev.) | ($0.29)/ 0 |
| Actual (EPS/Rev.) | $-0.29/ | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Tech and Biotech Catalysts | Michael | 43.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
